Sensorion SA (ALSEN) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.190x

Based on the latest financial reports, Sensorion SA (ALSEN) has a cash flow conversion efficiency ratio of -0.190x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-8.45 Million ≈ $-9.88 Million USD) by net assets (€44.48 Million ≈ $52.00 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Sensorion SA (ALSEN) market capitalisation for the company's overall valuation and market capitalisation.

Sensorion SA - Cash Flow Conversion Efficiency Trend (2012–2025)

This chart illustrates how Sensorion SA's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Sensorion SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sensorion SA ranked by their cash flow conversion efficiency. See Sensorion SA debt service capacity to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
Triple i Logistics Public Company Limited BK:III	0.022x
Inspired Entertainment Inc NASDAQ:INSE	-1.891x
JUTAL OFF.OIL SRVCS HD-01 F:I8O	N/A
Creades AB Series A LSE:0QI9	-0.001x
Chongkundang KO:001630	0.029x
Dat Phuong JSC VN:DPG	0.059x
Adriano Care SOCIMI SAU MC:YADR	0.009x
Sat Nusapersada Tbk JK:PTSN	0.031x

Annual Cash Flow Conversion Efficiency for Sensorion SA (2012–2025)

The table below shows the annual cash flow conversion efficiency of Sensorion SA from 2012 to 2025. View ALSEN stock price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€44.48 Million ≈ $52.00 Million	€-27.39 Million ≈ $-32.02 Million	-0.616x	-108.25%
2024-12-31	€72.14 Million ≈ $84.34 Million	€-21.33 Million ≈ $-24.94 Million	-0.296x	+53.30%
2023-12-31	€33.28 Million ≈ $38.90 Million	€-21.07 Million ≈ $-24.63 Million	-0.633x	+35.30%
2022-12-31	€21.87 Million ≈ $25.57 Million	€-21.41 Million ≈ $-25.02 Million	-0.979x	-299.56%
2021-12-31	€43.98 Million ≈ $51.42 Million	€-10.77 Million ≈ $-12.59 Million	-0.245x	-168.93%
2020-12-31	€58.35 Million ≈ $68.21 Million	€-5.31 Million ≈ $-6.21 Million	-0.091x	+91.51%
2019-12-31	€13.21 Million ≈ $15.45 Million	€-14.17 Million ≈ $-16.56 Million	-1.072x	+69.27%
2018-12-31	€3.51 Million ≈ $4.10 Million	€-12.25 Million ≈ $-14.32 Million	-3.489x	-228.29%
2017-12-31	€7.32 Million ≈ $8.56 Million	€-7.78 Million ≈ $-9.10 Million	-1.063x	-26.94%
2016-12-31	€8.59 Million ≈ $10.04 Million	€-7.19 Million ≈ $-8.41 Million	-0.837x	-112.45%
2015-12-31	€12.82 Million ≈ $14.99 Million	€-5.05 Million ≈ $-5.91 Million	-0.394x	-105.53%
2014-12-31	€-323.20K ≈ $-377.85K	€-2.30 Million ≈ $-2.69 Million	7.130x	+504.41%
2013-12-31	€-1.20 Million ≈ $-1.40 Million	€-1.42 Million ≈ $-1.66 Million	1.180x	+103.73%
2012-12-31	€26.11K ≈ $30.53K	€-826.03K ≈ $-965.71K	-31.636x	--

About Sensorion SA

PA:ALSEN France Biotechnology

Market Cap

$5.53 Billion

€4.73 Billion EUR

Market Cap Rank

#18527 Global

#268 in France

Share Price

€9.19

Change (1 day)

-2.29%

52-Week Range

€0.22 - €10.47

All Time High

€12.53